Conversations with the Living: The Haitian AIDS Crisis

The official blog of Conversations with the Living

Archive for the ‘European Union’ Category

India-EU Free Trade Agreement and the HIV+

leave a comment »

We reported on a proposed India-EU Free Trade Agreement back in November that has medical professionals, activists, and patients concerned that millions of HIV sufferers in the developing world will be without the drugs they need to survive.

Today, people in India have taken to the streets to demand that pharmaceutical companies, which stand to gain enormous profits from obtaining rights to create and distribute drugs at a price they see fit, do not block access to those that need the medication to survive.

Although the European Union denies that the agreement will negatively impact India’s generic medicine industry or patients access to these medications, there is little transparency, and until a draft of the agreement is made available criticism and concern over its contents will continue from medical professionals, HIV/AIDS activists and patients.

Here is the link to our posting in November.

https://conversationswiththeliving.wordpress.com/2010/11/13/constant-state-of-emergency/

Stay tuned for production updates…

Constant State of Emergency

leave a comment »

Photo Courtesy of Bryan Fletchall

The people of Haiti are fighters. A glimpse into the history of this proud and spirited nation will reveal that even amongst the most intense suffering; Haitian people are proud of and embrace their heritage, their culture, and their country.

There are so many incredibly beautiful things about Haiti; there is so much good lost and forgotten amidst the tragedy. As so rightly stated by Haitian-American author, Edwidge Danticat, “I think Haiti is a place that suffers so much from neglect that people only want to hear about it when it’s at its extreme. And that’s what they end up knowing about it. “

The people of Haiti are beautiful, their roots run deep, and their telling story of strength and resilience is one that has been written out of the history books. Even as they exist is a constant state of emergency, historically underserved and under acknowledged, they continue to fight and hope for a better future for Haiti and her people. Haiti’s historical suffering bleeds into the present, an ever-gaping wound of injustice, making the inaction of both Haitian and foreign governments to the continued crisis unsurprising, as it is nothing short of dismal, if not criminal.

Amongst the flooded tent cities surrounded by rubble, the cholera crisis deepens, killing hundreds and infecting thousands. Haiti has long struggled with poverty and disease, both directly linked to the nation’s history of exploitation by foreign powers with sinister agendas; agendas that have claimed millions of lives for the sake of international interests.

Curable and Manageable Disease

Curable and manageable disease has killed millions of people in Haiti and other developing countries for decades, even while the medicines to treat the affected population are available. The affected populations’ inability to access these medications is a human rights violation of the most basic and harmful kind. International government policy has long dictated access to these medications and a major component in facilitating their effective use – proper nourishment, i.e. food and water.

Impoverished governments unable to afford medications and trade agreements that have controlled the production, distribution and affordability of food and medicine have put Haiti and other developing countries in a constant state of emergency, because they have not had the opportunity to even build, let alone maintain a proper health care, industrial or agricultural infrastructure.

The current cholera epidemic in Haiti is another hurdle amongst a series of obstacles in a nation of fighters. The struggle to combat cholera is all too familiar, as Haiti has battled high infection rates of malaria, hepatitis, tuberculosis, and HIV/AIDS in the past and continues to in the present. Money and bureaucracy have always managed to hinder access to life-saving medicine, and as a result lives continue to be lost.

With limited access the major factor in determining the welfare of millions in mind, the following section discusses a pending trade agreement between the European Union and India that threatens to even further decrease access to medications in developing countries.

Pending Trade Agreement Possible Threat to HIV Sufferers

Patent laws have created a system where pharmaceutical companies stand to gain enormous profits from obtaining rights to create and distribute drugs at a price they see fit to gain profit with little regard for those who need access them. High demand equals expensive medicine and healthy profits for developers, while those who need the medications the most can’t acquire them. Simply, the pharmaceutical industry, without argument, control’s the fate of the world’s sick.

A possible international trade agreement between the European Union (EU) and India has medical professionals, activists, and patients concerned that millions of HIV sufferers in the developing world will be without the drugs they need to survive.

India’s generic pharmaceutical industry competes with these profit driven drug producers. Having been coined the “developing world’s pharmacy”, India, under its patent laws produces generic drugs that are distributed around the world, “bypassing a system designed to ensure drug developers are rewarded with a period of exclusive sales rights for new medicines.” As a result India has become the source of medicine for many of the world’s developing countries in order to treat the critically ill.

With access to generic drugs, the cost of treating patients with HIV has fallen from around $10,000 dollars a year in 2000 to just $70 a year today.

Not only has India’s generic production of medicines meant that its own population has benefitted from access to life-saving drugs, but as stated by Hans V. Hogerzeil, Director of Medicines Policy and Standards at the World Health Organization, “at least half of the five million Aids patients in Africa already on treatment rely on Indian generic medicines for their treatment.”

Although the European Union denies that the agreement will negatively impact India’s generic medicine industry, until a draft of the agreement is made available criticism and concern over its contents will continue from medical professionals, HIV/AIDS activists and patients.

Individuals infected with HIV/AIDS and other diseases can live long and productive lives if provided adequate nutrition and medicine. If treatment for the critically ill is made available and lives can been saved in developing countries where food, clean water and medical supplies are difficult to come by, a diagnosis once tantamount to a death sentence can be regarded as a manageable disease.

A link to the full article regarding the pending trade agreement is below.

Link: http://english.aljazeera.net/indepth/2010/10/2010102920031160477.html

– LC